Toward lentiviral vectors for antiangiogenic ocular gene therapy

Anne Louise Askou, Thomas Stax Jakobsen, Thomas J. Corydon

Open source

DOI
10.1016/j.omtm.2023.08.007
Published
2023-09
Container
Molecular Therapy - Methods & Clinical Development
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.omtm.2023.08.007,
  title = {Toward lentiviral vectors for antiangiogenic ocular gene therapy},
  author = {Anne Louise Askou and Thomas Stax Jakobsen and Thomas J. Corydon},
  year = {2023},
  journal = {Molecular Therapy - Methods \& Clinical Development},
  doi = {10.1016/j.omtm.2023.08.007},
  url = {https://doi.org/10.1016/j.omtm.2023.08.007}
}

RIS

TY  - JOUR
TI  - Toward lentiviral vectors for antiangiogenic ocular gene therapy
AU  - Anne Louise Askou
AU  - Thomas Stax Jakobsen
AU  - Thomas J. Corydon
PY  - 2023
JO  - Molecular Therapy - Methods & Clinical Development
DO  - 10.1016/j.omtm.2023.08.007
UR  - https://doi.org/10.1016/j.omtm.2023.08.007
ER  - 

APA

Askou, A. L., Jakobsen, T. S., & Corydon, T. J. (2023). Toward lentiviral vectors for antiangiogenic ocular gene therapy. Molecular Therapy - Methods & Clinical Development. https://doi.org/10.1016/j.omtm.2023.08.007

Source records